

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | humoral immune response (GO:0006959) | 9.28249474 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 8.19323456 |
| 3 | glomerular filtration (GO:0003094) | 7.06140142 |
| 4 | renal filtration (GO:0097205) | 6.34105201 |
| 5 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 6.21529627 |
| 6 | negative regulation of glucose import (GO:0046325) | 6.12355525 |
| 7 | signal peptide processing (GO:0006465) | 5.94305479 |
| 8 | regulation of respiratory burst (GO:0060263) | 5.83175293 |
| 9 | negative regulation of B cell proliferation (GO:0030889) | 5.64217804 |
| 10 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.29995091 |
| 11 | B cell receptor signaling pathway (GO:0050853) | 5.29651995 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.00291682 |
| 13 | negative regulation of glucose transport (GO:0010829) | 4.95528910 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 4.89232769 |
| 15 | Fc-epsilon receptor signaling pathway (GO:0038095) | 4.85721762 |
| 16 | Fc receptor signaling pathway (GO:0038093) | 4.79718650 |
| 17 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 4.53872320 |
| 18 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 4.34553204 |
| 19 | L-fucose catabolic process (GO:0042355) | 4.32537838 |
| 20 | fucose catabolic process (GO:0019317) | 4.32537838 |
| 21 | L-fucose metabolic process (GO:0042354) | 4.32537838 |
| 22 | detection of other organism (GO:0098543) | 4.32339928 |
| 23 | detection of bacterium (GO:0016045) | 4.29139719 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.27384976 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.27384976 |
| 26 | phenylpropanoid metabolic process (GO:0009698) | 4.25070740 |
| 27 | cellular response to zinc ion (GO:0071294) | 4.24780012 |
| 28 | regulation of B cell differentiation (GO:0045577) | 4.23847092 |
| 29 | regulation of B cell proliferation (GO:0030888) | 4.20102861 |
| 30 | keratinization (GO:0031424) | 4.16764250 |
| 31 | immune response-activating signal transduction (GO:0002757) | 3.95805763 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93653499 |
| 33 | germinal center formation (GO:0002467) | 3.87150574 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 3.83077208 |
| 35 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.71168378 |
| 36 | regulation of cellular extravasation (GO:0002691) | 3.66141901 |
| 37 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.64389391 |
| 38 | activation of immune response (GO:0002253) | 3.58223019 |
| 39 | chronic inflammatory response (GO:0002544) | 3.55928983 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.52488519 |
| 41 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.52147016 |
| 42 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.48911407 |
| 43 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.46703432 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.34640706 |
| 45 | positive regulation of immunoglobulin production (GO:0002639) | 3.32853710 |
| 46 | regulation of antigen processing and presentation (GO:0002577) | 3.28432105 |
| 47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.27715897 |
| 48 | regulation of integrin activation (GO:0033623) | 3.27543439 |
| 49 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.26356846 |
| 50 | cellular response to type I interferon (GO:0071357) | 3.22828197 |
| 51 | type I interferon signaling pathway (GO:0060337) | 3.22828197 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.20706200 |
| 53 | negative regulation of cell killing (GO:0031342) | 3.20706200 |
| 54 | response to type I interferon (GO:0034340) | 3.18711293 |
| 55 | proline biosynthetic process (GO:0006561) | 3.15457481 |
| 56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.14385855 |
| 57 | cellular extravasation (GO:0045123) | 3.11471390 |
| 58 | B cell proliferation (GO:0042100) | 3.10979627 |
| 59 | production of molecular mediator of immune response (GO:0002440) | 3.08302254 |
| 60 | B cell mediated immunity (GO:0019724) | 3.06240964 |
| 61 | surfactant homeostasis (GO:0043129) | 3.03282035 |
| 62 | protein-chromophore linkage (GO:0018298) | 3.02965129 |
| 63 | regulation of water loss via skin (GO:0033561) | 3.01648709 |
| 64 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.01327930 |
| 65 | complement activation, classical pathway (GO:0006958) | 26.8565039 |
| 66 | complement activation (GO:0006956) | 20.5940807 |
| 67 | establishment of skin barrier (GO:0061436) | 2.99196043 |
| 68 | detection of biotic stimulus (GO:0009595) | 2.98060904 |
| 69 | negative regulation of B cell activation (GO:0050869) | 2.97888543 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97525531 |
| 71 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.95527671 |
| 72 | positive regulation of macrophage cytokine production (GO:0060907) | 2.91596688 |
| 73 | peptidyl-asparagine modification (GO:0018196) | 2.91034366 |
| 74 | negative thymic T cell selection (GO:0045060) | 2.89915408 |
| 75 | positive regulation of antigen processing and presentation (GO:0002579) | 2.89710745 |
| 76 | regulation of B cell activation (GO:0050864) | 2.89266322 |
| 77 | response to interleukin-15 (GO:0070672) | 2.87490902 |
| 78 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.85505468 |
| 79 | positive regulation of response to oxidative stress (GO:1902884) | 2.85505468 |
| 80 | defense response to protozoan (GO:0042832) | 2.84180984 |
| 81 | antibacterial humoral response (GO:0019731) | 2.81611716 |
| 82 | positive regulation of Rap GTPase activity (GO:0032854) | 2.79844897 |
| 83 | tissue homeostasis (GO:0001894) | 2.78617107 |
| 84 | eosinophil chemotaxis (GO:0048245) | 2.78203048 |
| 85 | COPI coating of Golgi vesicle (GO:0048205) | 2.77823962 |
| 86 | Golgi transport vesicle coating (GO:0048200) | 2.77823962 |
| 87 | maternal placenta development (GO:0001893) | 2.76457545 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.76452491 |
| 89 | wound healing, spreading of epidermal cells (GO:0035313) | 2.76393551 |
| 90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.71782150 |
| 91 | respiratory burst (GO:0045730) | 2.71488739 |
| 92 | protein N-linked glycosylation (GO:0006487) | 2.71340686 |
| 93 | skin morphogenesis (GO:0043589) | 2.69653023 |
| 94 | detection of molecule of bacterial origin (GO:0032490) | 2.68021079 |
| 95 | cellular response to interferon-gamma (GO:0071346) | 2.67156808 |
| 96 | antimicrobial humoral response (GO:0019730) | 2.67005548 |
| 97 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.66962747 |
| 98 | NIK/NF-kappaB signaling (GO:0038061) | 2.64903093 |
| 99 | positive regulation of protein homooligomerization (GO:0032464) | 2.64723877 |
| 100 | regulation of T cell migration (GO:2000404) | 2.63443669 |
| 101 | positive regulation of nuclease activity (GO:0032075) | 2.63030444 |
| 102 | negative T cell selection (GO:0043383) | 2.62663253 |
| 103 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.60957872 |
| 104 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.60949033 |
| 105 | eosinophil migration (GO:0072677) | 2.60480885 |
| 106 | neutrophil activation involved in immune response (GO:0002283) | 2.59185227 |
| 107 | negative regulation of humoral immune response (GO:0002921) | 2.58512200 |
| 108 | macrophage activation involved in immune response (GO:0002281) | 2.58179393 |
| 109 | negative regulation of complement activation (GO:0045916) | 2.56317146 |
| 110 | positive regulation of T cell migration (GO:2000406) | 2.55925915 |
| 111 | intestinal epithelial cell development (GO:0060576) | 2.55650829 |
| 112 | cellular response to unfolded protein (GO:0034620) | 2.55499606 |
| 113 | I-kappaB phosphorylation (GO:0007252) | 2.55175260 |
| 114 | N-acetylneuraminate metabolic process (GO:0006054) | 2.52992062 |
| 115 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.52694467 |
| 116 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.51766700 |
| 117 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51064222 |
| 118 | modulation by symbiont of host defense response (GO:0052031) | 2.51064222 |
| 119 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51064222 |
| 120 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.51064222 |
| 121 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51064222 |
| 122 | modulation by symbiont of host immune response (GO:0052553) | 2.51064222 |
| 123 | GDP-mannose metabolic process (GO:0019673) | 2.50860726 |
| 124 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.49727088 |
| 125 | regulation of nuclease activity (GO:0032069) | 2.49482568 |
| 126 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.49425058 |
| 127 | lymph node development (GO:0048535) | 2.49391676 |
| 128 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.48869359 |
| 129 | multicellular organismal water homeostasis (GO:0050891) | 2.47626473 |
| 130 | negative regulation of interleukin-12 production (GO:0032695) | 2.46832585 |
| 131 | response to interferon-gamma (GO:0034341) | 2.46586652 |
| 132 | N-glycan processing (GO:0006491) | 2.45416588 |
| 133 | T-helper 1 type immune response (GO:0042088) | 2.44554543 |
| 134 | regulation of lymphocyte migration (GO:2000401) | 2.43824814 |
| 135 | mannose metabolic process (GO:0006013) | 2.43143127 |
| 136 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.41134368 |
| 137 | regulation of immunoglobulin production (GO:0002637) | 2.40750968 |
| 138 | mast cell activation (GO:0045576) | 2.40471923 |
| 139 | regulation of Rap GTPase activity (GO:0032317) | 2.40359670 |
| 140 | defense response to Gram-negative bacterium (GO:0050829) | 2.36610462 |
| 141 | thymic T cell selection (GO:0045061) | 2.35846941 |
| 142 | bone resorption (GO:0045453) | 2.34110829 |
| 143 | mature B cell differentiation (GO:0002335) | 2.31946470 |
| 144 | ER-nucleus signaling pathway (GO:0006984) | 2.31077491 |
| 145 | cellular response to topologically incorrect protein (GO:0035967) | 2.30046327 |
| 146 | regulation of B cell apoptotic process (GO:0002902) | 2.29951638 |
| 147 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.29507961 |
| 148 | negative regulation of interleukin-10 production (GO:0032693) | 2.27462683 |
| 149 | B cell homeostasis (GO:0001782) | 2.26504300 |
| 150 | xenobiotic catabolic process (GO:0042178) | 2.26082018 |
| 151 | negative regulation of osteoclast differentiation (GO:0045671) | 2.24477303 |
| 152 | regulation of superoxide anion generation (GO:0032928) | 2.24413747 |
| 153 | T cell selection (GO:0045058) | 2.20961297 |
| 154 | polyketide metabolic process (GO:0030638) | 2.20825631 |
| 155 | doxorubicin metabolic process (GO:0044598) | 2.20825631 |
| 156 | daunorubicin metabolic process (GO:0044597) | 2.20825631 |
| 157 | regulation of gamma-delta T cell activation (GO:0046643) | 2.17467426 |
| 158 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.17346750 |
| 159 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.15935118 |
| 160 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.15770802 |
| 161 | protein activation cascade (GO:0072376) | 13.4038710 |
| 162 | Fc-gamma receptor signaling pathway (GO:0038094) | 11.4205523 |
| 163 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 11.4205523 |
| 164 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 11.4205523 |
| 165 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 11.2808867 |
| 166 | retina homeostasis (GO:0001895) | 10.5858301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.88257241 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.65838314 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.16006324 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.75338482 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.74117709 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.27791582 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.94875355 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.86994470 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.69342536 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.62524581 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.62358273 |
| 12 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.51075335 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10135029 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.03696121 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.89869138 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.75810216 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.64947269 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.64439482 |
| 19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.60658012 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.56091902 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40775885 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.30738270 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28555343 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.20768385 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.19755646 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.19402711 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15801995 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.10797153 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07894418 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.07425567 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.03300823 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98027757 |
| 33 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94856021 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92514986 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.86214991 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.85288396 |
| 37 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.79634015 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78748149 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77916329 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75417951 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74053379 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.68198164 |
| 43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.66216114 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.65529922 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64656330 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63528112 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62473629 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61959856 |
| 49 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59887233 |
| 50 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59263992 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57175820 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.54481380 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54186167 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.51718052 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47832210 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43298154 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42972806 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36447245 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33166097 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32866495 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32169777 |
| 62 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31032002 |
| 63 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.30439843 |
| 64 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.30334007 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29031400 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27387593 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26432264 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26114085 |
| 69 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.25565776 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25362372 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 1.25126666 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24142563 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23666752 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22137053 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20925436 |
| 76 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20101587 |
| 77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19098838 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18198551 |
| 79 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17425914 |
| 80 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15890825 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12819142 |
| 82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12115682 |
| 83 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11520422 |
| 84 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11449668 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09847771 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09760608 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08594080 |
| 88 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07824890 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06611593 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05994316 |
| 91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.05800749 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05697410 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05476287 |
| 94 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.04224852 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03405164 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01871356 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00036223 |
| 98 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99599374 |
| 99 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98116135 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96981250 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96542994 |
| 102 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96192340 |
| 103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95486025 |
| 104 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94473611 |
| 105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93851532 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93562558 |
| 107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92762174 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92459374 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92095684 |
| 110 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.91842489 |
| 111 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91767807 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91729926 |
| 113 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91654998 |
| 114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90933314 |
| 115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88103300 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87860375 |
| 117 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86971900 |
| 118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86971900 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85373561 |
| 120 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84852426 |
| 121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84715667 |
| 122 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84604058 |
| 123 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84433530 |
| 124 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83422342 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81077679 |
| 126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80247747 |
| 127 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79993740 |
| 128 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.79798087 |
| 129 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79579980 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78880275 |
| 131 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78783622 |
| 132 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.78472865 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77533005 |
| 134 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76072229 |
| 135 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.73744834 |
| 136 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.73272976 |
| 137 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.73008410 |
| 138 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.72724978 |
| 139 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72494937 |
| 140 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72261065 |
| 141 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71956758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.50682149 |
| 2 | MP0003724_increased_susceptibility_to | 4.95519573 |
| 3 | MP0001800_abnormal_humoral_immune | 4.77635849 |
| 4 | MP0003303_peritoneal_inflammation | 4.51959170 |
| 5 | MP0001790_abnormal_immune_system | 3.66096924 |
| 6 | MP0005387_immune_system_phenotype | 3.66096924 |
| 7 | MP0005671_abnormal_response_to | 3.54586828 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.40321092 |
| 9 | MP0002723_abnormal_immune_serum | 2.91898389 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.74435851 |
| 11 | MP0006054_spinal_hemorrhage | 2.74248920 |
| 12 | MP0001819_abnormal_immune_cell | 2.69038456 |
| 13 | MP0002398_abnormal_bone_marrow | 2.60794124 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.60045027 |
| 15 | MP0000716_abnormal_immune_system | 2.56230632 |
| 16 | MP0000685_abnormal_immune_system | 2.50798204 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.48995151 |
| 18 | MP0005275_abnormal_skin_tensile | 2.37105093 |
| 19 | MP0000689_abnormal_spleen_morphology | 2.23332078 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.21357776 |
| 21 | MP0001879_abnormal_lymphatic_vessel | 2.19385483 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.15210789 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 2.13527218 |
| 24 | MP0005025_abnormal_response_to | 2.13159925 |
| 25 | MP0002429_abnormal_blood_cell | 2.08427662 |
| 26 | MP0002796_impaired_skin_barrier | 2.05026202 |
| 27 | MP0005166_decreased_susceptibility_to | 2.01613556 |
| 28 | MP0004782_abnormal_surfactant_physiolog | 1.93905976 |
| 29 | MP0002006_tumorigenesis | 1.91335388 |
| 30 | MP0002419_abnormal_innate_immunity | 1.90974025 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.85065873 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.83809124 |
| 33 | MP0002722_abnormal_immune_system | 1.81583310 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.79709472 |
| 35 | MP0003436_decreased_susceptibility_to | 1.78603628 |
| 36 | MP0004947_skin_inflammation | 1.77749267 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.75673037 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.65826830 |
| 39 | MP0008004_abnormal_stomach_pH | 1.58980492 |
| 40 | MP0005360_urolithiasis | 1.56570143 |
| 41 | MP0004264_abnormal_extraembryonic_tissu | 1.55957103 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.49693865 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.48591011 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.45298409 |
| 45 | MP0002405_respiratory_system_inflammati | 1.41477000 |
| 46 | MP0005023_abnormal_wound_healing | 1.41173005 |
| 47 | MP0009764_decreased_sensitivity_to | 1.40233063 |
| 48 | MP0003763_abnormal_thymus_physiology | 1.40120037 |
| 49 | MP0000920_abnormal_myelination | 1.34748889 |
| 50 | MP0001873_stomach_inflammation | 1.31747700 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.31707299 |
| 52 | MP0009785_altered_susceptibility_to | 1.31593143 |
| 53 | MP0003448_altered_tumor_morphology | 1.30399310 |
| 54 | MP0008438_abnormal_cutaneous_collagen | 1.28663321 |
| 55 | MP0003045_fibrosis | 1.27560726 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.26697127 |
| 57 | MP0001851_eye_inflammation | 1.24137923 |
| 58 | MP0000343_altered_response_to | 1.22138222 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.19869175 |
| 60 | MP0006082_CNS_inflammation | 1.17013729 |
| 61 | MP0004858_abnormal_nervous_system | 1.16162209 |
| 62 | MP0008569_lethality_at_weaning | 1.15923761 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.15604696 |
| 64 | MP0005310_abnormal_salivary_gland | 1.14783571 |
| 65 | MP0000858_altered_metastatic_potential | 1.11840607 |
| 66 | MP0003279_aneurysm | 1.09619697 |
| 67 | MP0009046_muscle_twitch | 1.08393595 |
| 68 | MP0005164_abnormal_response_to | 1.07174535 |
| 69 | MP0003866_abnormal_defecation | 1.05581901 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 1.04574473 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.04314282 |
| 72 | MP0002019_abnormal_tumor_incidence | 1.03286071 |
| 73 | MP0004510_myositis | 1.03229460 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.03046763 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.01667030 |
| 76 | MP0004859_abnormal_synaptic_plasticity | 1.00991213 |
| 77 | MP0002933_joint_inflammation | 1.00726902 |
| 78 | MP0001216_abnormal_epidermal_layer | 0.98863473 |
| 79 | MP0005390_skeleton_phenotype | 0.98560966 |
| 80 | MP0008872_abnormal_physiological_respon | 0.98328481 |
| 81 | MP0003828_pulmonary_edema | 0.98240536 |
| 82 | MP0002136_abnormal_kidney_physiology | 0.98219245 |
| 83 | MP0001853_heart_inflammation | 0.98019111 |
| 84 | MP0000249_abnormal_blood_vessel | 0.96286991 |
| 85 | MP0003075_altered_response_to | 0.95255691 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.94723596 |
| 87 | MP0005501_abnormal_skin_physiology | 0.92339230 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91641066 |
| 89 | MP0002060_abnormal_skin_morphology | 0.91030896 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.90474151 |
| 91 | MP0003690_abnormal_glial_cell | 0.90450515 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.89836112 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.88460436 |
| 94 | MP0008469_abnormal_protein_level | 0.85934545 |
| 95 | MP0009278_abnormal_bone_marrow | 0.83743997 |
| 96 | MP0000490_abnormal_crypts_of | 0.83503902 |
| 97 | MP0000609_abnormal_liver_physiology | 0.82356489 |
| 98 | MP0001919_abnormal_reproductive_system | 0.82118867 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.80244533 |
| 100 | MP0001545_abnormal_hematopoietic_system | 0.80244533 |
| 101 | MP0005388_respiratory_system_phenotype | 0.80224456 |
| 102 | MP0002133_abnormal_respiratory_system | 0.80224456 |
| 103 | MP0003868_abnormal_feces_composition | 0.80048191 |
| 104 | MP0003186_abnormal_redox_activity | 0.78712927 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.76123914 |
| 106 | MP0001663_abnormal_digestive_system | 0.74246895 |
| 107 | MP0005623_abnormal_meninges_morphology | 0.73446889 |
| 108 | MP0005332_abnormal_amino_acid | 0.73405009 |
| 109 | MP0009643_abnormal_urine_homeostasis | 0.72022453 |
| 110 | MP0008874_decreased_physiological_sensi | 0.71946359 |
| 111 | MP0003795_abnormal_bone_structure | 0.71619953 |
| 112 | MP0001542_abnormal_bone_strength | 0.70766917 |
| 113 | MP0010678_abnormal_skin_adnexa | 0.70514110 |
| 114 | MP0005503_abnormal_tendon_morphology | 0.69617778 |
| 115 | MP0003183_abnormal_peptide_metabolism | 0.69115248 |
| 116 | MP0000604_amyloidosis | 0.68869691 |
| 117 | MP0001666_abnormal_nutrient_absorption | 0.68762654 |
| 118 | MP0000579_abnormal_nail_morphology | 0.66993656 |
| 119 | MP0003091_abnormal_cell_migration | 0.66963686 |
| 120 | MP0002254_reproductive_system_inflammat | 0.66682992 |
| 121 | MP0008875_abnormal_xenobiotic_pharmacok | 0.66405615 |
| 122 | MP0001958_emphysema | 0.66284760 |
| 123 | MP0009931_abnormal_skin_appearance | 0.65955308 |
| 124 | MP0004808_abnormal_hematopoietic_stem | 0.65738143 |
| 125 | MP0003252_abnormal_bile_duct | 0.64928607 |
| 126 | MP0008260_abnormal_autophagy | 0.64519008 |
| 127 | MP0002083_premature_death | 0.64364984 |
| 128 | MP0002873_normal_phenotype | 0.64147863 |
| 129 | MP0002169_no_abnormal_phenotype | 0.63996701 |
| 130 | MP0008057_abnormal_DNA_replication | 0.63216072 |
| 131 | MP0005076_abnormal_cell_differentiation | 0.62502253 |
| 132 | MP0009765_abnormal_xenobiotic_induced | 0.61001231 |
| 133 | MP0001533_abnormal_skeleton_physiology | 0.60489864 |
| 134 | MP0000003_abnormal_adipose_tissue | 0.58075392 |
| 135 | MP0009763_increased_sensitivity_to | 0.57940688 |
| 136 | MP0000733_abnormal_muscle_development | 0.57846519 |
| 137 | MP0005083_abnormal_biliary_tract | 0.57795669 |
| 138 | MP0002693_abnormal_pancreas_physiology | 0.57148883 |
| 139 | MP0005058_abnormal_lysosome_morphology | 0.57117300 |
| 140 | MP0010329_abnormal_lipoprotein_level | 0.55990590 |
| 141 | MP0002168_other_aberrant_phenotype | 0.55588604 |
| 142 | MP0000013_abnormal_adipose_tissue | 0.55313952 |
| 143 | MP0008873_increased_physiological_sensi | 0.54509583 |
| 144 | MP0001191_abnormal_skin_condition | 0.54311494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.13269984 |
| 2 | Prostate neoplasm (HP:0100787) | 8.75597739 |
| 3 | Abnormality of B cell number (HP:0010975) | 8.72537058 |
| 4 | B lymphocytopenia (HP:0010976) | 8.72537058 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.69006301 |
| 6 | Recurrent bronchitis (HP:0002837) | 6.39994115 |
| 7 | Abnormality of macrophages (HP:0004311) | 6.25839472 |
| 8 | Cellulitis (HP:0100658) | 6.18936459 |
| 9 | Colitis (HP:0002583) | 6.18632650 |
| 10 | Abnormality of the prostate (HP:0008775) | 5.81602304 |
| 11 | Verrucae (HP:0200043) | 5.75332781 |
| 12 | Papilloma (HP:0012740) | 5.75332781 |
| 13 | Recurrent viral infections (HP:0004429) | 5.21458878 |
| 14 | Gastrointestinal stroma tumor (HP:0100723) | 5.19568877 |
| 15 | IgM deficiency (HP:0002850) | 5.15624589 |
| 16 | Meningitis (HP:0001287) | 4.74761628 |
| 17 | Recurrent pneumonia (HP:0006532) | 4.57666559 |
| 18 | Inflammation of the large intestine (HP:0002037) | 4.42371784 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 4.24500403 |
| 20 | Chronic otitis media (HP:0000389) | 4.07226652 |
| 21 | Chronic sinusitis (HP:0011109) | 4.00303342 |
| 22 | Thyroiditis (HP:0100646) | 3.96612694 |
| 23 | Leukocytosis (HP:0001974) | 3.94546280 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.92709760 |
| 25 | Osteomyelitis (HP:0002754) | 3.73253065 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.71397214 |
| 27 | Recurrent otitis media (HP:0000403) | 3.68675648 |
| 28 | Recurrent lower respiratory tract infections (HP:0002783) | 3.65867139 |
| 29 | Bronchitis (HP:0012387) | 3.60153576 |
| 30 | Abnormality of male internal genitalia (HP:0000022) | 3.39753573 |
| 31 | Sepsis (HP:0100806) | 3.36222640 |
| 32 | IgG deficiency (HP:0004315) | 3.32028390 |
| 33 | Abnormality of nail color (HP:0100643) | 3.31159818 |
| 34 | Emphysema (HP:0002097) | 3.14321162 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 3.05858436 |
| 36 | Neoplasm of the lung (HP:0100526) | 3.04853561 |
| 37 | Skin rash (HP:0000988) | 3.00422314 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 2.98266341 |
| 39 | IgA deficiency (HP:0002720) | 2.89175789 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.86004072 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.83413264 |
| 42 | Abnormality of T cells (HP:0002843) | 2.80584823 |
| 43 | Hypoplasia of the thymus (HP:0000778) | 2.78288506 |
| 44 | Orchitis (HP:0100796) | 2.77686509 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.76206519 |
| 46 | Vasculitis (HP:0002633) | 2.75613872 |
| 47 | T lymphocytopenia (HP:0005403) | 2.75259918 |
| 48 | Mitral stenosis (HP:0001718) | 2.74164312 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.72598296 |
| 50 | Neoplasm of the respiratory system (HP:0100606) | 2.66643900 |
| 51 | Right ventricular cardiomyopathy (HP:0011663) | 2.63145191 |
| 52 | Hyperactive renin-angiotensin system (HP:0000841) | 2.62822925 |
| 53 | Alopecia of scalp (HP:0002293) | 2.62436638 |
| 54 | Restrictive lung disease (HP:0002091) | 2.61741039 |
| 55 | Gangrene (HP:0100758) | 2.57957752 |
| 56 | Hematochezia (HP:0002573) | 2.57360009 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.51864585 |
| 58 | Glomerulonephritis (HP:0000099) | 2.51586810 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50046315 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.47688547 |
| 61 | Optic neuritis (HP:0100653) | 2.47688547 |
| 62 | Gingivitis (HP:0000230) | 2.47383164 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46857909 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 2.46171760 |
| 65 | Hypermelanotic macule (HP:0001034) | 2.45941954 |
| 66 | Nephritis (HP:0000123) | 2.43985033 |
| 67 | Hemoptysis (HP:0002105) | 2.43820622 |
| 68 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.43599517 |
| 69 | Recurrent bacterial skin infections (HP:0005406) | 2.43401865 |
| 70 | Gingival bleeding (HP:0000225) | 2.43379006 |
| 71 | Lymphopenia (HP:0001888) | 2.42520455 |
| 72 | Abnormality of complement system (HP:0005339) | 2.41915444 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.36570790 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35097868 |
| 75 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.34766881 |
| 76 | Premature loss of primary teeth (HP:0006323) | 2.32688937 |
| 77 | Malnutrition (HP:0004395) | 2.31259867 |
| 78 | Combined immunodeficiency (HP:0005387) | 2.28581066 |
| 79 | Severe combined immunodeficiency (HP:0004430) | 2.26695464 |
| 80 | Peritonitis (HP:0002586) | 2.25645142 |
| 81 | Increased IgM level (HP:0003496) | 2.20200061 |
| 82 | Abnormality of the peritoneum (HP:0002585) | 2.18763522 |
| 83 | Nasal polyposis (HP:0100582) | 2.17507786 |
| 84 | Complement deficiency (HP:0004431) | 2.15669339 |
| 85 | Onycholysis (HP:0001806) | 2.15624083 |
| 86 | Skin ulcer (HP:0200042) | 2.15044326 |
| 87 | Recurrent skin infections (HP:0001581) | 2.13628968 |
| 88 | Pustule (HP:0200039) | 2.12405950 |
| 89 | Myositis (HP:0100614) | 2.10641712 |
| 90 | Mucosal telangiectasiae (HP:0100579) | 2.09498667 |
| 91 | Acrocyanosis (HP:0001063) | 2.07904323 |
| 92 | Pulmonary infiltrates (HP:0002113) | 2.07225127 |
| 93 | Chest pain (HP:0100749) | 2.02667087 |
| 94 | Polycythemia (HP:0001901) | 2.02308633 |
| 95 | Erythema (HP:0010783) | 2.01834848 |
| 96 | Xerostomia (HP:0000217) | 2.01527775 |
| 97 | Palmoplantar hyperkeratosis (HP:0000972) | 2.01414399 |
| 98 | Granulocytopenia (HP:0001913) | 1.99769835 |
| 99 | Corneal erosion (HP:0200020) | 1.99026051 |
| 100 | Pruritus (HP:0000989) | 1.98398926 |
| 101 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.96096751 |
| 102 | Neutropenia (HP:0001875) | 1.95214660 |
| 103 | Autoimmune thrombocytopenia (HP:0001973) | 1.94531660 |
| 104 | Abnormality of the nasal mucosa (HP:0000433) | 1.93785775 |
| 105 | Bronchiectasis (HP:0002110) | 1.92434340 |
| 106 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91260135 |
| 107 | Hypertensive crisis (HP:0100735) | 1.90138713 |
| 108 | Epistaxis (HP:0000421) | 1.89051218 |
| 109 | Deep venous thrombosis (HP:0002625) | 1.88062309 |
| 110 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84807104 |
| 111 | Hypoproteinemia (HP:0003075) | 1.81922354 |
| 112 | Eosinophilia (HP:0001880) | 1.81380850 |
| 113 | Arthralgia (HP:0002829) | 1.79381528 |
| 114 | Macroorchidism (HP:0000053) | 1.77961839 |
| 115 | Eczematoid dermatitis (HP:0000976) | 1.71878317 |
| 116 | Lymphoma (HP:0002665) | 1.67263183 |
| 117 | Papilledema (HP:0001085) | 1.64281709 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 1.63999285 |
| 119 | Mediastinal lymphadenopathy (HP:0100721) | 1.62752978 |
| 120 | Leukopenia (HP:0001882) | 1.61773184 |
| 121 | Thrombocytosis (HP:0001894) | 1.61518176 |
| 122 | Teleangiectasia of the skin (HP:0100585) | 1.57585006 |
| 123 | Dysostosis multiplex (HP:0000943) | 1.55883037 |
| 124 | Small epiphyses (HP:0010585) | 1.55709227 |
| 125 | Keratoconjunctivitis sicca (HP:0001097) | 1.54917554 |
| 126 | Dehydration (HP:0001944) | 1.52583770 |
| 127 | Conjunctival hamartoma (HP:0100780) | 1.52219398 |
| 128 | Colon cancer (HP:0003003) | 1.51798376 |
| 129 | Limb hypertonia (HP:0002509) | 1.51621723 |
| 130 | Viral hepatitis (HP:0006562) | 1.51516478 |
| 131 | Recurrent cutaneous fungal infections (HP:0011370) | 1.45881710 |
| 132 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.45881710 |
| 133 | Keratoconjunctivitis (HP:0001096) | 1.44952902 |
| 134 | Abnormal gallbladder morphology (HP:0012437) | 1.44292575 |
| 135 | Abnormality of eosinophils (HP:0001879) | 1.43961107 |
| 136 | Exercise-induced myalgia (HP:0003738) | 1.43556424 |
| 137 | Abnormal foot bone ossification (HP:0010675) | 1.43488359 |
| 138 | Cholelithiasis (HP:0001081) | 1.43292064 |
| 139 | Abnormality of the common coagulation pathway (HP:0010990) | 1.42392297 |
| 140 | Hypergammaglobulinemia (HP:0010702) | 1.42148785 |
| 141 | Camptodactyly of toe (HP:0001836) | 1.39958575 |
| 142 | Supranuclear gaze palsy (HP:0000605) | 1.38735206 |
| 143 | Obstructive lung disease (HP:0006536) | 1.37115132 |
| 144 | Chronic obstructive pulmonary disease (HP:0006510) | 1.37115132 |
| 145 | Increased IgE level (HP:0003212) | 1.35253289 |
| 146 | Urticaria (HP:0001025) | 1.34539308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.90292848 |
| 2 | MAP4K1 | 4.94744092 |
| 3 | RIPK4 | 3.26774011 |
| 4 | GRK6 | 2.98673596 |
| 5 | PKN2 | 2.63900977 |
| 6 | MST1R | 2.56614987 |
| 7 | TYK2 | 2.53457360 |
| 8 | MAP3K10 | 2.50242075 |
| 9 | SYK | 2.49480313 |
| 10 | TXK | 2.46965615 |
| 11 | SIK2 | 2.39121946 |
| 12 | CSF1R | 2.15083764 |
| 13 | PIK3CA | 2.13817623 |
| 14 | PRPF4B | 2.11149530 |
| 15 | KIT | 2.08742141 |
| 16 | MAP3K13 | 2.04113287 |
| 17 | TAOK3 | 2.00607775 |
| 18 | MAP3K14 | 2.00030876 |
| 19 | EPHA3 | 1.99191012 |
| 20 | IRAK1 | 1.94816150 |
| 21 | BLK | 1.91344317 |
| 22 | RIPK1 | 1.84417926 |
| 23 | ZAP70 | 1.79468590 |
| 24 | BTK | 1.75777835 |
| 25 | IRAK4 | 1.74513914 |
| 26 | FLT3 | 1.73844138 |
| 27 | NME2 | 1.65826218 |
| 28 | LYN | 1.64675605 |
| 29 | JAK1 | 1.58313226 |
| 30 | PRKCH | 1.57080911 |
| 31 | BCKDK | 1.54384898 |
| 32 | EIF2AK3 | 1.53640992 |
| 33 | ITK | 1.52174697 |
| 34 | TBK1 | 1.50713079 |
| 35 | MET | 1.49391607 |
| 36 | FES | 1.47096043 |
| 37 | IRAK3 | 1.46519658 |
| 38 | BMPR2 | 1.33761965 |
| 39 | CAMKK2 | 1.33669444 |
| 40 | PIK3CG | 1.31702593 |
| 41 | FGFR3 | 1.29434081 |
| 42 | STK10 | 1.27367979 |
| 43 | NEK2 | 1.25663956 |
| 44 | HCK | 1.25479878 |
| 45 | CLK1 | 1.24261591 |
| 46 | HIPK2 | 1.22917343 |
| 47 | MAP3K4 | 1.15675324 |
| 48 | BUB1 | 1.15293605 |
| 49 | MAP3K1 | 1.15143919 |
| 50 | SIK1 | 1.14445080 |
| 51 | MAP3K3 | 1.11598664 |
| 52 | BRSK2 | 1.09794507 |
| 53 | FRK | 1.09360446 |
| 54 | FGFR4 | 1.08468317 |
| 55 | IRAK2 | 1.07753361 |
| 56 | FER | 1.07677743 |
| 57 | BMX | 1.03466908 |
| 58 | MST4 | 1.03056773 |
| 59 | STK24 | 1.02878913 |
| 60 | PDK2 | 1.02795938 |
| 61 | FGFR2 | 1.02377004 |
| 62 | PRKCQ | 1.01356389 |
| 63 | PIM1 | 0.97912411 |
| 64 | GRK5 | 0.97243074 |
| 65 | MAP2K3 | 0.95721217 |
| 66 | TGFBR2 | 0.93305912 |
| 67 | IKBKB | 0.92684363 |
| 68 | TTN | 0.92535365 |
| 69 | PDGFRA | 0.92506928 |
| 70 | LRRK2 | 0.91236319 |
| 71 | JAK3 | 0.90392463 |
| 72 | LCK | 0.90085748 |
| 73 | MAP3K9 | 0.89524356 |
| 74 | IKBKE | 0.87595172 |
| 75 | PRKD1 | 0.82149292 |
| 76 | KSR2 | 0.78192600 |
| 77 | EEF2K | 0.77882260 |
| 78 | SIK3 | 0.73664494 |
| 79 | CSK | 0.73307797 |
| 80 | UHMK1 | 0.71927094 |
| 81 | ALK | 0.71214040 |
| 82 | CAMKK1 | 0.70844979 |
| 83 | FYN | 0.69596654 |
| 84 | MATK | 0.69343544 |
| 85 | TAOK1 | 0.69323350 |
| 86 | NEK9 | 0.67172634 |
| 87 | RET | 0.66071536 |
| 88 | IGF1R | 0.65335548 |
| 89 | PKN1 | 0.64512223 |
| 90 | MAPK12 | 0.57138990 |
| 91 | TGFBR1 | 0.56636197 |
| 92 | DDR2 | 0.56219504 |
| 93 | NLK | 0.55323112 |
| 94 | TEC | 0.54822012 |
| 95 | MARK3 | 0.53351959 |
| 96 | GRK1 | 0.51008761 |
| 97 | JAK2 | 0.50683100 |
| 98 | MAP3K5 | 0.50517133 |
| 99 | PRKCD | 0.50386054 |
| 100 | MAPK4 | 0.49984479 |
| 101 | TAOK2 | 0.49276787 |
| 102 | MAPK7 | 0.48767070 |
| 103 | MAP3K6 | 0.47387984 |
| 104 | LMTK2 | 0.45352833 |
| 105 | YES1 | 0.43952057 |
| 106 | PDK1 | 0.42695720 |
| 107 | CSNK1A1L | 0.42654803 |
| 108 | EPHA2 | 0.42352310 |
| 109 | PDPK1 | 0.42027331 |
| 110 | CSNK1G3 | 0.41422196 |
| 111 | PRKD2 | 0.38542055 |
| 112 | BRSK1 | 0.37042047 |
| 113 | PDGFRB | 0.36905704 |
| 114 | INSR | 0.36365252 |
| 115 | ABL1 | 0.35318287 |
| 116 | CDC42BPA | 0.35164880 |
| 117 | CSNK1G2 | 0.35154108 |
| 118 | ADRBK2 | 0.33325500 |
| 119 | MAP3K7 | 0.31755375 |
| 120 | MAP3K11 | 0.30236745 |
| 121 | RPS6KA6 | 0.29728408 |
| 122 | MAPK11 | 0.28829697 |
| 123 | MAP3K2 | 0.27361821 |
| 124 | NEK1 | 0.27040602 |
| 125 | CDK12 | 0.26089753 |
| 126 | CHUK | 0.25917042 |
| 127 | RPS6KL1 | 0.25814734 |
| 128 | RPS6KC1 | 0.25814734 |
| 129 | ADRBK1 | 0.24799915 |
| 130 | ACVR1B | 0.23585794 |
| 131 | MAPK3 | 0.23325519 |
| 132 | MAPKAPK2 | 0.23103322 |
| 133 | CDK6 | 0.22268474 |
| 134 | NTRK3 | 0.22060236 |
| 135 | MAP3K8 | 0.21786828 |
| 136 | EGFR | 0.21541800 |
| 137 | TRIB3 | 0.20292806 |
| 138 | CDK5 | 0.20120144 |
| 139 | PRKCI | 0.19816235 |
| 140 | SRC | 0.19589956 |
| 141 | RPS6KB2 | 0.17904924 |
| 142 | FGR | 0.17429381 |
| 143 | EPHB1 | 0.17284377 |
| 144 | CSNK1G1 | 0.16451320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 8.95902858 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.40302988 |
| 3 | Protein export_Homo sapiens_hsa03060 | 4.38372925 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.03795188 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.88841926 |
| 6 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.64037731 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.34533672 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.26573181 |
| 9 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.24602128 |
| 10 | Asthma_Homo sapiens_hsa05310 | 1.77190855 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74399639 |
| 12 | Influenza A_Homo sapiens_hsa05164 | 1.60060227 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.59332531 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.49129448 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47454684 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44219672 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41133205 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39796151 |
| 19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.38806641 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38374123 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32656008 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27842510 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25188992 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23997762 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.15209162 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14104685 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.12402874 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.11538498 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.06348418 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01957217 |
| 31 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.01765515 |
| 32 | Malaria_Homo sapiens_hsa05144 | 0.99617717 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 0.95543505 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94959189 |
| 35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.94951295 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92986586 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 0.92686389 |
| 38 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92125449 |
| 39 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90225511 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 0.89708214 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88431147 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86913848 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86584295 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84514195 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82344412 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80685764 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 0.79833079 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 0.78912243 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78906824 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78461656 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76651915 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75498592 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74334834 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72902232 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69617655 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68447944 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67182502 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65618594 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65333529 |
| 60 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.65060911 |
| 61 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63266722 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61700260 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.60026777 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59934979 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59819324 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59283279 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58452438 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57606148 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57221661 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56192940 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55771646 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55197627 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53630927 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.52043433 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51306576 |
| 76 | Proteasome_Homo sapiens_hsa03050 | 0.51261908 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50633133 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50572899 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.50146120 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.49913463 |
| 81 | DNA replication_Homo sapiens_hsa03030 | 0.49154326 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48548056 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.48325857 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48071438 |
| 85 | Shigellosis_Homo sapiens_hsa05131 | 0.47374147 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.47338606 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47218320 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45961785 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45554047 |
| 90 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.44784387 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43451379 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43293217 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43197269 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.43168211 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40891199 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.40399118 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39903892 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39291440 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39059002 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38951145 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38621475 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38036415 |
| 103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37977686 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37778697 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.37687177 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37573072 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36556083 |
| 108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34689781 |
| 109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34023623 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33234970 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32972640 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32753919 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32540486 |
| 114 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32335675 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.32100742 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30293101 |
| 117 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.29287213 |
| 118 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29278006 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29227673 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.28817517 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28336735 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27211332 |
| 123 | Base excision repair_Homo sapiens_hsa03410 | 0.26362840 |
| 124 | Cocaine addiction_Homo sapiens_hsa05030 | 0.25521576 |
| 125 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.24642646 |
| 126 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.24319798 |
| 127 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24050397 |
| 128 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23883080 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.23524093 |
| 130 | Alzheimers disease_Homo sapiens_hsa05010 | 0.23130903 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22921746 |
| 132 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.22808621 |
| 133 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.22741808 |
| 134 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.22605542 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22513461 |
| 136 | Insulin secretion_Homo sapiens_hsa04911 | 0.22450615 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.21916684 |
| 138 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20394288 |
| 139 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.19623606 |
| 140 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19403301 |
| 141 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.18697601 |
| 142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.18557837 |
| 143 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.17962481 |
| 144 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.16502928 |
| 145 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16357841 |

